109 related articles for article (PubMed ID: 18201784)
21. Prolonged exposure to high insulin impairs the endothelial PI3-kinase/Akt/nitric oxide signalling.
Madonna R; De Caterina R
Thromb Haemost; 2009 Feb; 101(2):345-50. PubMed ID: 19190820
[TBL] [Abstract][Full Text] [Related]
22. Induction of endothelial nitric oxide synthase, SIRT1, and catalase by statins inhibits endothelial senescence through the Akt pathway.
Ota H; Eto M; Kano MR; Kahyo T; Setou M; Ogawa S; Iijima K; Akishita M; Ouchi Y
Arterioscler Thromb Vasc Biol; 2010 Nov; 30(11):2205-11. PubMed ID: 20705918
[TBL] [Abstract][Full Text] [Related]
23. [Effects of obstructive sleep apnea style intermittent hypoxia on endothelin-1, nitric oxide, and nitric oxide synthase in endothelium: experiment with human umbilical vein endothelial cells].
Zhao HY; Chen BY; Cao J; Feng J; Guo MN
Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(31):2189-92. PubMed ID: 18001528
[TBL] [Abstract][Full Text] [Related]
24. Basal nitric oxide release attenuates cell migration of HeLa and endothelial cells.
Bulotta S; Ierardi MV; Maiuolo J; Cattaneo MG; Cerullo A; Vicentini LM; Borgese N
Biochem Biophys Res Commun; 2009 Sep; 386(4):744-9. PubMed ID: 19559671
[TBL] [Abstract][Full Text] [Related]
25. Statin treatment and 3' polyadenylation of eNOS mRNA.
Kosmidou I; Moore JP; Weber M; Searles CD
Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2642-9. PubMed ID: 17916773
[TBL] [Abstract][Full Text] [Related]
26. Adverse balance of nitric oxide/peroxynitrite in the dysfunctional endothelium can be reversed by statins.
Heeba G; Hassan MK; Khalifa M; Malinski T
J Cardiovasc Pharmacol; 2007 Oct; 50(4):391-8. PubMed ID: 18049306
[TBL] [Abstract][Full Text] [Related]
27. Pitavastatin, an HMG-CoA reductase inhibitor, exerts eNOS-independent protective actions against angiotensin II induced cardiovascular remodeling and renal insufficiency.
Yagi S; Aihara K; Ikeda Y; Sumitomo Y; Yoshida S; Ise T; Iwase T; Ishikawa K; Azuma H; Akaike M; Matsumoto T
Circ Res; 2008 Jan; 102(1):68-76. PubMed ID: 17967781
[TBL] [Abstract][Full Text] [Related]
28. Rosuvastatin prevents endothelial cell death and reduces atherosclerotic lesion formation in ApoE-deficient mice.
Enomoto S; Sata M; Fukuda D; Nakamura K; Nagai R
Biomed Pharmacother; 2009 Jan; 63(1):19-26. PubMed ID: 18162361
[TBL] [Abstract][Full Text] [Related]
29. Endothelial nitric oxide synthase is essential for the HMG-CoA reductase inhibitor cerivastatin to promote collateral growth in response to ischemia.
Sata M; Nishimatsu H; Suzuki E; Sugiura S; Yoshizumi M; Ouchi Y; Hirata Y; Nagai R
FASEB J; 2001 Nov; 15(13):2530-2. PubMed ID: 11641268
[TBL] [Abstract][Full Text] [Related]
30. The effect of n-3 PUFA on eNOS activity and expression in Ea hy 926 cells.
Gousset-Dupont A; Robert V; Grynberg A; Lacour B; Tardivel S
Prostaglandins Leukot Essent Fatty Acids; 2007 Mar; 76(3):131-9. PubMed ID: 17229561
[TBL] [Abstract][Full Text] [Related]
31. FGF-2 overexpression opposes the beta amyloid toxic injuries to the vascular endothelium.
Donnini S; Cantara S; Morbidelli L; Giachetti A; Ziche M
Cell Death Differ; 2006 Jul; 13(7):1088-96. PubMed ID: 16410806
[TBL] [Abstract][Full Text] [Related]
32. Fluvastatin reduces pulmonary vein spontaneous activity through nitric oxide pathway.
Hu YF; Chen YC; Cheng CC; Higa S; Chen YJ; Chen SA
J Cardiovasc Electrophysiol; 2009 Feb; 20(2):200-6. PubMed ID: 18775044
[TBL] [Abstract][Full Text] [Related]
33. FHL-2 suppresses VEGF-induced phosphatidylinositol 3-kinase/Akt activation via interaction with sphingosine kinase-1.
Hayashi H; Nakagami H; Takami Y; Koriyama H; Mori M; Tamai K; Sun J; Nagao K; Morishita R; Kaneda Y
Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):909-14. PubMed ID: 19325137
[TBL] [Abstract][Full Text] [Related]
34. Low-energy laser irradiation increases endothelial cell proliferation, migration, and eNOS gene expression possibly via PI3K signal pathway.
Chen CH; Hung HS; Hsu SH
Lasers Surg Med; 2008 Jan; 40(1):46-54. PubMed ID: 18220263
[TBL] [Abstract][Full Text] [Related]
35. Effects of statins on nitric oxide/cGMP signaling in human umbilical vein endothelial cells.
Meda C; Plank C; Mykhaylyk O; Schmidt K; Mayer B
Pharmacol Rep; 2010; 62(1):100-12. PubMed ID: 20360620
[TBL] [Abstract][Full Text] [Related]
36. Pravastatin accelerates ischemia-induced angiogenesis through AMP-activated protein kinase.
Izumi Y; Shiota M; Kusakabe H; Hikita Y; Nakao T; Nakamura Y; Muro T; Miura K; Yoshiyama M; Iwao H
Hypertens Res; 2009 Aug; 32(8):675-9. PubMed ID: 19498441
[TBL] [Abstract][Full Text] [Related]
37. Downregulation of survivin expression and elevation of caspase-3 activity involved in pitavastatin-induced HepG 2 cell apoptosis.
Wang J; Xu Z; Zhang M
Oncol Rep; 2007 Aug; 18(2):383-7. PubMed ID: 17611660
[TBL] [Abstract][Full Text] [Related]
38. [oxLDL reduced endothelial progenitor cells survival and function via regulating Akt/eNOS signal pathway].
Ma FX; Ren Q; Han ZC
Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Feb; 35(2):173-7. PubMed ID: 17445417
[TBL] [Abstract][Full Text] [Related]
39. Xanthine oxidase interaction with vascular endothelial growth factor in human endothelial cell angiogenesis.
Kou B; Ni J; Vatish M; Singer DR
Microcirculation; 2008 Apr; 15(3):251-67. PubMed ID: 18386220
[TBL] [Abstract][Full Text] [Related]
40. Stimulatory effects of low-dose 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor fluvastatin on hepatocyte growth factor-induced angiogenesis: involvement of p38 mitogen-activated protein kinase.
Uruno A; Sugawara A; Kudo M; Satoh F; Saito A; Ito S
Hypertens Res; 2008 Nov; 31(11):2085-96. PubMed ID: 19098381
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
